Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Medsol RX
CoreAge Rx and Medsol RX both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxMedsol RX
Ranked #200 · Grade C
Best for: A mother weighing a plan against paying monthly, who wants the totals to add up and will take the packages page over the homepage.
Visit Medsol RXThe verdict
CoreAge Rx edges out Medsol RX on the Rx-Readiness Score, 95 to 53 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Medsol RX is still a genuine option — cost a year out and the plans make sense: $1,548 for twelve months of semaglutide against $2,358 paying month to month, so committing saves $810. What does not make sense is that three pages of this site quote three different prices for the same treatment, the highest being a $550 a month that nothing in the plans reaches. The plan totals themselves are exact — all six of them. The tablet plans, however, tell you that what arrives is tirzepatide. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Medsol RX |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 53/100 · C |
| Overall rank | #1 | #200 |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $149/mo | $259/mo |
| Coverage | All 50 states | Not published; describes itself as serving patients nationwide |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Medsol RX
Ranked #200 · Grade C
What we like
- A real month-to-month path priced openly alongside the plans
- All six plan totals recompute to the exact dollar — $507, $894, $1,548, $687, $1,254, $2,388
- Both molecules priced separately, plus a tablet option and brand-name pens
The caveats
- Three pages, three semaglutide prices, and a $200-$550 range the plans never reach
- The advertised $169 lasts one month; the ongoing figure is $199
- The oral semaglutide plan cards list "Tirzepatide injection supply" as what is included
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Medsol RX against other providers on our shortlist.
Or browse the full comparison hub.